Insulin Resistance, Dopamine Disruption & MASLD
A Four-Stage Metabolic Cascade — Phase One Is The Root Cause
Dopamine & Serotonin Depletion — Depression, Anxiety or Low Mood
Not a character issue — a direct metabolic outcome. Depending on constitution: depression, anxiety, fatigue or chronic low motivation.
↓ Tyrosine Hydroxylase
IDO → Kynurenine Pathway
Brain Reward Circuit Impaired
↓ Dopamine & Serotonin
PHASE FOUR
TNF-α & IL-6 cross the blood-brain barrier → suppress neurotransmitter synthesis
MASLD — Metabolic Fatty Liver Disease
Fat-laden liver cells release TNF-α and IL-6 into systemic circulation. Gut dysbiosis reduces dopamine and serotonin precursors. The liver loses its capacity to regulate neurochemical substrates and clear inflammatory mediators.
TNF-α & IL-6 Elevation
Gut Dysbiosis
↓ Neurotransmitter Precursors
Oxidative Stress
PHASE THREE
Liver fat accumulation → oxidative stress → chronic low-grade systemic inflammation
Hypertension & Hepatic Fat Accumulation
Kidneys — remaining insulin-sensitive — aggressively retain sodium, raising blood pressure. Hyperinsulinaemia simultaneously drives the liver to convert glucose into fat (de novo lipogenesis). Fat builds in liver cells. Autophagy and cellular repair are suppressed.
Renal Sodium Retention
RAAS Activation
De Novo Lipogenesis
Elevated Blood Pressure
PHASE TWO
Kidneys retain sodium → fluid volume rises → blood pressure increases & liver accumulates fat
PHASE ONE — Insulin Resistance: The Root Cause
Cells stop responding to insulin. The body acts as if feeding is continuous and storage is always needed — retaining sodium and water. Only the kidneys and liver remain fully insulin-sensitive, bearing the entire metabolic burden of this hidden dysfunction.
Elevated Fasting Insulin
HOMA-IR ≥ 1.9
Pancreatic Overcompensation
Silent — Often Undetected For Years
One reversible root cause. Sources: Psychoneuroendocrinology · Brain, Behaviour & Immunity · Journal of Clinical Investigation · Frontiers in Cardiovascular Medicine